Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Jan 23, 2015 10:39pm
281 Views
Post# 23358412

Link to New York based Lannett Generics product catalogue..

Link to New York based Lannett Generics product catalogue..just a bit of recearch but the catalogue , link below, shows the 30 approx generics Lannett sells.. IMO this is one of the closest public companies to NPH in terms of product  portfolio..

https://www.lannett.com/docs/Lannett_Catalog_2014.pdf

I talked about this company already ... I would be real curious what percent of Lannett's portfolio could be sourced in India (if anyone knows)... I am assuming about 20%....as most seem unique and newer...chime in if you havemore  info..

Lannett has a 1.6 billion US ---about 2 billion CDN market cap... and they are totally focused on Generic Pharmaceuticals of the traditional chemical compund type pills --- exactly like NPH...

Assuming most of this portfolio is not available elsewhere, I would highly recommend, sometime after NPH;s initial launch has been established,  that communication is established with them...



Bullboard Posts